ArticleFuture oncology (London, England)2025
Management of trastuzumab deruxtecan-related adverse events in breast cancer: Italian expert panel recommendations.
Giampaolo Bianchini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it